"Cystectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Used for excision of the urinary bladder.
Descriptor ID |
D015653
|
MeSH Number(s) |
E04.950.774.150
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cystectomy".
Below are MeSH descriptors whose meaning is more specific than "Cystectomy".
This graph shows the total number of publications written about "Cystectomy" by people in this website by year, and whether "Cystectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 4 | 6 | 10 |
1997 | 1 | 3 | 4 |
1998 | 3 | 0 | 3 |
1999 | 2 | 2 | 4 |
2000 | 1 | 2 | 3 |
2001 | 3 | 9 | 12 |
2002 | 2 | 1 | 3 |
2003 | 4 | 7 | 11 |
2004 | 5 | 2 | 7 |
2005 | 2 | 1 | 3 |
2006 | 16 | 9 | 25 |
2007 | 7 | 11 | 18 |
2008 | 14 | 6 | 20 |
2009 | 9 | 8 | 17 |
2010 | 16 | 4 | 20 |
2011 | 6 | 6 | 12 |
2012 | 7 | 2 | 9 |
2013 | 5 | 3 | 8 |
2014 | 15 | 4 | 19 |
2015 | 5 | 6 | 11 |
2016 | 10 | 6 | 16 |
2017 | 7 | 5 | 12 |
2018 | 10 | 7 | 17 |
2019 | 9 | 8 | 17 |
2020 | 9 | 11 | 20 |
2021 | 7 | 10 | 17 |
2022 | 2 | 10 | 12 |
2023 | 3 | 12 | 15 |
2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cystectomy" by people in Profiles.
-
Predicting Response to Intravesical Bacillus Calmette-Gu?rin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort. J Urol. 2025 Feb; 213(2):192-204.
-
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer. N Engl J Med. 2024 Oct 03; 391(13):1206-1216.
-
Bladder-sparing Therapy for Bacillus Calmette-Gu?rin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. Eur Urol. 2024 Dec; 86(6):516-527.
-
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial. Eur Urol. 2024 Oct; 86(4):297-300.
-
Evaluating the Differences of Wound Related Complications in Robotically Assisted Radical Cystectomy vs Open Radical Cystectomy. Urology. 2024 Aug; 190:56-62.
-
Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database. Urol Oncol. 2024 Oct; 42(10):332.e11-332.e19.
-
Sterile Water Versus Glycine in Transurethral Resection of Bladder Tumors-Immunogenic and Clinical Implications. Eur Urol Focus. 2024 Sep; 10(5):796-804.
-
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU Int. 2024 Jun; 133(6):733-741.
-
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Clin Cancer Res. 2024 01 17; 30(2):444-449.
-
Open vs Robotic Cystectomy: Case Closed? J Urol. 2024 Mar; 211(3):473-475.